Published in AIDS Weekly, January 14th, 2002
The advance was made by researchers in the University of California, San Diego (UCSD) School of Medicine and VA San Diego Healthcare System.
Described in the December 2001 issue of the Journal of Biological Chemistry, the test makes it possible to study and design new compounds to block the action of these molecular components before HIV can permanently infect a normal cell, causing it to manufacture more virus.
In recognition of the test as "groundbreaking work...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.